Fellow's platform provided data for five studies that will be presented at the AUA 2026 Annual Meeting. The studies draw on a network of >3,000 clinical practices.

The Y Factor, a Houston-based men’s health platform focused on fertility, sexual performance & hormone optimization, announced a strategic partnership with Fellow.

Fellow Health today announced that industry executive and private equity advisor Paul Kappelman has been appointed Independent Chairman of the Board.

Fellow Health announced today the close of a $24 million Series B financing round led by 5AM Ventures, with new participation from The Forest Road Company.

Fellow Semen Analysis is now a covered benefit for eligible Progyny members to support the growing need for semen analysis as a critical step in the fertility care journey.

Fellow received a high-complexity laboratory permit from the NYS Department of Health Clinical Laboratory Evaluation Program, and approval for its post-vasectomy test.

Fellow presented studies highlighting mail-in semen analysis as a potential post-PSA reflex test as well as an alternative to in-clinic post-vasectomy semen analysis (PVSA).

Fellow announced research showing that seminal plasma is a rich source of cell free DNA from somatic cells and provides new insights into its potential as a liquid biopsy.

Fellow announced reserach findings demonstrating that its mail-in postvasectomy semen analysis (PVSA) kits significantly improve compliance rates.

Fellow achieved a significant milestone of delivering more than 100,000 patient test results since its product launch in 2020.